图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
免疫病理疾病及治疗学论文学
SJR: 0.309 SNIP: 0.041 CiteScore™: 0.18

ISSN 打印: 2151-8017
ISSN 在线: 2151-8025

Archives: Volume 1, 2010 to Volume 7, 2016

免疫病理疾病及治疗学论文学

DOI: 10.1615/ForumImmunDisTher.2016016605
pages 143-156

Tissue Cross-Talk and Exosomal-MicroRNAs

Micol Marchetti
Bristol Renal, University of Bristol, Dorothy Hocking Building, Whitson Street, BS1 3NY, Bristol, UK

ABSTRACT

Over the last 10 years, the interest in microRNAs has grown rapidly, and the characterization of these short non-coding RNA sequences has become crucial due to their involvement and role in several widespread diseases such as cancer, cardiovascular diseases, kidney diseases, and diabetes, as well as developmental diseases. The increased understanding of the biology of microRNAs has triggered the development of important tools to study their function and new therapeutic opportunities to treat disease, offering a clear example of how the scientific translational approach plays a crucial role in scientific research in the 21st century. More recently, this interest in microRNAs has increased further as a result of the discovery of exosome microRNAs, microRNAs contained in endogenous vesicles isolated from biological fluids such as breast milk, blood, serum, urine, cerebrospinal fluid, and semen. MicroRNAs represent powerful potential biomarkers for the detection of diseases at an early stage, when the chances of successful treatment and outcomes (drug mediated or surgical) are higher. Furthermore, recent publications have highlighted the role of exosomal microRNAs in cell-to-cell communication, adding new information to the importance of these exosome and vesicles. Much work still needs to be done to better understand the biogenesis and loading and dispersion of exosomes and microvesicles as well to characterize the exosomal content in terms of functionality and activity, but current data already suggest that these exosomes could be potential therapeutic targets.


Articles with similar content:

Noncoding RNAs (ncRNA) in Hepato Cancer: A Review
Journal of Environmental Pathology, Toxicology and Oncology, Vol.37, 2018, issue 1
Xiujuan Sun, Anshoo Malhotra
Atopic Dermatitis: Drug Delivery Approaches in Disease Management
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 4
Jitendra Baweja, Manisha Lalan, Ambikanandan Misra
From Targets to Targeted Therapies in Hepatocellular Carcinoma
Forum on Immunopathological Diseases and Therapeutics, Vol.5, 2014, issue 3-4
Melchiorre Cervello, Antonella Cusimano, Maria Rita Emma, Antonina Azzolina, Giuseppa Augello, James A. McCubrey, Daniele Balasus
An Overview of Culinary and Medicinal Mushrooms in Neurodegeneration and Neurotrauma Research
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 3
Chai-Chee Ng, Kah-Hui Wong, Gowri Kanagasabapathy, Yoon-Yen Yow, Vikineswary Sabaratnam
Oral Colon-Specific Drug Delivery of Protein and Peptide Drugs
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.24, 2007, issue 1
Ruchita V. Kumar, Sanjay Singh, Vivek Ranjan Sinha, J. R. Bhinge, Asmita Singh, Rachana Kumria